1 | Additional Representation Sheet | 03 Mar 2004 |
1 | Examination Report | 03 Mar 2004 |
10 | TM-46 | 23 Dec 2015 |
11 | TM-R(RENEWAL OF TRADE MARK) | 09 Jan 2024 |
2 | Additional Representation Sheet | 03 Mar 2004 |
2 | Certificate | 03 Mar 2004 |
3 | Examination Report | 03 Mar 2004 |
3 | Power of Attorney | 03 Mar 2004 |
4 | Certificate | 03 Mar 2004 |
4 | Other Documents | 03 Mar 2004 |
5 | Other Documents | 03 Mar 2004 |
5 | Power of Attorney | 03 Mar 2004 |
6 | Note Sheet | 03 Mar 2004 |
6 | TM-1 | 03 Mar 2004 |
7 | Note Sheet | 03 Mar 2004 |
7 | TM-1 | 03 Mar 2004 |
8 | Certificate | 19 Feb 2014 |
8 | TM-12 | 19 Feb 2014 |
9 | Certificate | 19 Feb 2014 |
9 | TM-12 | 19 Feb 2014 |
1 | O3 NOTICE | 16791746 | 6409838 | 12 Dec 2023 |
2 | RENEWAL INTIMATION LETTER | 17131688 | 13 Jan 2024 |
The application for Rancilin was made on 03 March 2004.
The trademark applicant for Rancilin is SUN PHARMACEUTICAL INDUSTRIES.
Rancilin is applied in class(es) 5.
Application for Rancilin is on Registered stage.
Application Id allotted to Rancilin is 1270447.
Rancilin filed with the Intellectual property office as a WORD.